44 related articles for article (PubMed ID: 34090832)
1. Autoantibodes to GP210 are a metric for UDCA responses in primary biliary cholangitis.
Wang C; Qin Z; Zhang M; Dai Y; Zhang L; Tian W; Gong Y; Chen S; Yang C; Xu P; Shi X; Zhao W; Timilsina S; Gershwin ME; Chen W; Qiu F; Liu X
J Transl Autoimmun; 2024 Jun; 8():100239. PubMed ID: 38550612
[TBL] [Abstract][Full Text] [Related]
2. Clinical Performance of the Line Immunoassay and Digital Liquid Chip Method for Detecting Autoimmune Liver Disease Autoantibodies.
Lv H; Deng A; Chen Y; Su Z
Arch Pathol Lab Med; 2024 Jun; ():. PubMed ID: 38830630
[TBL] [Abstract][Full Text] [Related]
3. Anti-mitochondrial M2 Antibodies and Myopathy: Author's Reply.
Konishi H; Fukuzawa K; Mori S; Satomi-Kobayashi S; Kiuchi K; Suzuki A; Akita T; Yano Y; Yoshida A; Hirata KI
Intern Med; 2018 Apr; 57(8):1189. PubMed ID: 29279475
[No Abstract] [Full Text] [Related]
4. Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease.
Cortez-Pinto H; Liberal R; Lopes S; Machado MV; Carvalho J; Dias T; Santos A; Agostinho C; Figueiredo P; Loureiro R; Martins A; Alexandrino G; Cotrim I; Leal C; Presa J; Mesquita M; Nunes J; Gouveia C; Vale AHE; Alves AL; Coelho M; Maia L; Pedroto I; Banhudo A; Pinto JS; Gomes MV; Oliveira J; Andreozzi V; Calinas F
United European Gastroenterol J; 2021 Jul; 9(6):699-706. PubMed ID: 34102008
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive diagnosis and follow-up of primary biliary cholangitis.
Corpechot C; Heurgue A; Tanne F; Potier P; Hanslik B; Decraecker M; de Lédinghen V; Ganne-Carrié N; Bureau C; Bourlière M
Clin Res Hepatol Gastroenterol; 2022 Jan; 46(1):101770. PubMed ID: 34332135
[TBL] [Abstract][Full Text] [Related]
6. The Evolving Use of Biochemical Markers in the Management of Primary Biliary Cholangitis: Discussion.
Kowdley KV; Hirschfield GM; Jones DE
Gastroenterol Hepatol (N Y); 2021 May; 17(5 Suppl 5):14-17. PubMed ID: 34135722
[No Abstract] [Full Text] [Related]
7. Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: A Retrospective Diagnosis.
Al-Handola R; Chinnappan J; Hussain M; Mahgoub A; Bachuwa G
Cureus; 2023 Mar; 15(3):e36309. PubMed ID: 37073193
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Prognostic Value of Monocyte-to-Lymphocyte Ratio and Red Cell Distribution Width to Lymphocyte Ratio in Primary Biliary Cholangitis.
Jiang Y; Wang J; Wu H; Zhou W; Li S; Jin M
Turk J Gastroenterol; 2023 Feb; 34(2):170-176. PubMed ID: 36620932
[TBL] [Abstract][Full Text] [Related]
9. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.
Bizzaro N; Covini G; Rosina F; Muratori P; Tonutti E; Villalta D; Pesente F; Alessio MG; Tampoia M; Antico A; Platzgummer S; Porcelli B; Terzuoli L; Liguori M; Bassetti D; Brusca I; Almasio PL; Tarantino G; Bonaguri C; Agostinis P; Bredi E; Tozzoli R; Invernizzi P; Selmi C
Clin Rev Allergy Immunol; 2012 Jun; 42(3):288-97. PubMed ID: 21188646
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune Markers in Primary Biliary Cholangitis.
Shah SK; Bowlus CL
Clin Liver Dis; 2024 Feb; 28(1):93-101. PubMed ID: 37945165
[TBL] [Abstract][Full Text] [Related]
11. Anti-gp210 and anti-Sp100 antibodies in primary biliary cholangitis.
Ben Lamine Z; Ben Jazia I; Ben Ahmed M; Ben Slama A; Baccouche A; Slama F; Jemaa A; Ghedira I; Mankaï A
Arab J Gastroenterol; 2021 Dec; 22(4):316-320. PubMed ID: 34090832
[TBL] [Abstract][Full Text] [Related]
12. Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis.
Jaskowski TD; Nandakumar V; Novis CL; Palmer M; Tebo AE
Clin Chim Acta; 2023 Feb; 540():117219. PubMed ID: 36610465
[TBL] [Abstract][Full Text] [Related]
13. Clinical performance of AMA-M2, anti-gp210 and anti-sp100 antibody levels in primary biliary cholangitis: When detected by multiplex bead-based flow fluorescent immunoassay.
Wang Z; Li Y; Ren L; Li Y; Xu T; Li W; Gao W; Sun G; Liu M
Immun Inflamm Dis; 2024 Jan; 12(1):e1161. PubMed ID: 38270327
[TBL] [Abstract][Full Text] [Related]
14. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis].
Xiao H; Chen JW; Xie X; Liu YM; Li F
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):209-14. PubMed ID: 22516989
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
